Hylla
Titel och upphov The complex connection between cannabis and schizophrenia
Utgivning, distribution etc. London : Elsevier/Academic Press, 2018
Fysisk beskrivning xiv, 347 pages : illustrations
Anmärkning: Innehåll An introduction to the complex connection between cannabis and schizophrenia / Marc W. Manseau, Michael T. Compton -- The epidemiology of cannabis use in the United States / Wilson M. Compton, Beth Han -- Cannabinoids and the brain / David L. Atkinson, Jeff K. Abbott -- Psychotomimetic and cognitive effects of ⁹ - tetrahydrocannabinol in laboratory settings / John D. Cahill, Swapnil, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza -- Psychotomimetic and cognitive effects of cannabis use in the general population / Nadia Solowij -- The association between cannabis use and schizotypy / Angelo B. Cedeño -- Effects of cannabis use in those at ultra-high risk for psychosis / Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, Patrick McGorry -- Cannabis-induced psychotic disorders / Luca Pauselli -- Synthetic cannabinoids and synthetic cannabinoid-induced psychotic disorders / Papanti Duccio, Schifano Fabrizio, Orsolini Laura -- Cannabis use as an independent risk factor for, or component cause of, schizophrenia and related psychotic disorders / Jodi M. Gilman, Sara M. Sobolewski, Anne Eden Evins -- Cannabis use as a determinant of earlier age at onset of schizophrenia and related psychotic disorders / Claire Ramsay Wan, Beth Broussard -- The prevalence and effects of cannabis use among individuals with schizophrenia and related psychotic disorders / Ana Fresán, Rebeca Robles-García, Carlos-Alfonso Tovilla-Zarate -- The treatment of cannabis use disorder among individuals with a psychotic disorders / Peter Bosanac, Ana Lusicic, David J. Castle -- Cannabidol as a potential novel therapeutic agent for psychotic disorders / Serena Deiana, Erica Zamberletti.
Term
Indexterm - Okontrollerad
Personnamn
ISBN
*00001252pam 122003617i 4500
*00129053
*00520171123120908.0
*008170915s2018 xxk|||| |00| 0|eng c
*020 $a978-0-12-804791-0$qpocket
*035 $a(BOKR)9780128047910
*035 $a(SE-LIBR)21532924
*084 $aVlnb$2kssb/8
*084 $aOhib$2kssb/8
*084 $aVlaaa$2kssb/8
*24514$aThe complex connection between cannabis and schizophrenia /$cedited by Michael T. Compton, Marc W. Manseau
*264 1$aLondon :$bElsevier/Academic Press,$c2018
*300 $axiv, 347 pages :$billustrations
*336 $btxt$2rdacontent
*337 $bn$2rdamedia
*338 $bnc$2rdacarrier
*5050 $aAn introduction to the complex connection between cannabis and schizophrenia / Marc W. Manseau, Michael T. Compton -- The epidemiology of cannabis use in the United States / Wilson M. Compton, Beth Han -- Cannabinoids and the brain / David L. Atkinson, Jeff K. Abbott -- Psychotomimetic and cognitive effects of ⁹ - tetrahydrocannabinol in laboratory settings / John D. Cahill, Swapnil, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza -- Psychotomimetic and cognitive effects of cannabis use in the general population / Nadia Solowij -- The association between cannabis use and schizotypy / Angelo B. Cedeño -- Effects of cannabis use in those at ultra-high risk for psychosis / Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, Patrick McGorry -- Cannabis-induced psychotic disorders / Luca Pauselli -- Synthetic cannabinoids and synthetic cannabinoid-induced psychotic disorders / Papanti Duccio, Schifano Fabrizio, Orsolini Laura -- Cannabis use as an independent risk factor for, or component cause of, schizophrenia and related psychotic disorders / Jodi M. Gilman, Sara M. Sobolewski, Anne Eden Evins -- Cannabis use as a determinant of earlier age at onset of schizophrenia and related psychotic disorders / Claire Ramsay Wan, Beth Broussard -- The prevalence and effects of cannabis use among individuals with schizophrenia and related psychotic disorders / Ana Fresán, Rebeca Robles-García, Carlos-Alfonso Tovilla-Zarate -- The treatment of cannabis use disorder among individuals with a psychotic disorders / Peter Bosanac, Ana Lusicic, David J. Castle -- Cannabidol as a potential novel therapeutic agent for psychotic disorders / Serena Deiana, Erica Zamberletti.
*650 4$aSchizophrenia
*650 4$aCannabinoids
*650 4$aPsychopharmacology
*650 4$aPsychoses, substance-induced
*653 $aSchizofreni
*653 $aCannabis
*653 $aCannabinoider
*653 $aPsykofarmakologi
*653 $aPsykoser
*7001 $aCompton, Michael T.$4edt
*7001 $aManseau, Marc W.$4edt
*852 $h4c101
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.